DaVita HealthCare Partners Inc.
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
34.29%
Market Cap
10.74 Bil.
P/E Ratio
11.94
Dividend Yield
0.00 %
Earnings per Share
8.43 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 167.35 G | 0 Units |
| PRICE DETERMINATION TIME | 06/03/2026 / 09:56:48 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 168.8 | 160.75 |
| PREV. DAY'S PRICE | 160.75 | (06/02) |
| CHANGE DAY BEFORE | +6.60 | 4.11 % |
| 52 WEEK HIGH / LOW | 173.15 (05/22) | 86.64 (01/14) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 14.53 | 12.53 | 8.43 | 9.92 | 6.86 |
| DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| DIVIDEND YIELD IN % | - | - | 0.00 % | 0.00 % | 0.00 % |
| DIVIDEND GROWTH IN % | - | - | - | - | - |
| PRICE - EARNINGS RATIO | 11.62 | 13.48 | 11.94 | 13.94 | 14.12 |
| PRICE - BOOK RATIO | - | - | - | 99.44 | 8.81 |
| PRICE - SALES RATIO | - | - | 0.63 | 1.02 | 0.80 |
| PRICE - CASH FLOW RATIO | - | - | 4.57 | 6.43 | 4.73 |
Master Data
| WKN | 897914 |
| ISIN | US23918K1088 |
| SYMBOL | TRL |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | DaVita |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | US Dollar |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | 64.20 Mil. |
| MARKET CAPITALISATION | 10.74 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -4.17 % | 22.34 % | 21.87 % | 56.83 % | 34.29 % | 83.42 % | 64.23 % | 67.80 % |
| HIGH | 169.45 | 173.15 | 173.15 | 173.15 | 173.15 | 173.15 | 173.15 | 173.15 |
| LOW | 160.40 | 127.30 | 121.30 | 86.64 | 86.64 | 69.26 | 65.03 | 86.64 |
Dividend
per share
DaVita does not deliver dividend information
Company profile
DaVita, Inc. engages in the provision of medical care services. It operates through the US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives segments. The US Dialysis and Related Lab Services segment offer kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consists primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
Structured products for DaVita HealthCare Partners Inc.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.